# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-072447
Filing Date
2025-07-31
Accepted
2025-07-31 07:01:06
Documents
41
Period of Report
2025-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2522155d1_8k.htm iXBRL | 8-K | 26787
2 | EXHIBIT 99.1 | tm2522155d1_ex99-1.htm | EX-99.1 | 142349
3 | EXHIBIT 99.2 | tm2522155d1_ex99-2.htm | EX-99.2 | 39252
7 | GRAPHIC | tm2522155d1_ex99-1img01.jpg | GRAPHIC | 2782
8 | GRAPHIC | tm2522155d1_ex99-2img001.jpg | GRAPHIC | 210985
9 | GRAPHIC | tm2522155d1_ex99-2img002.jpg | GRAPHIC | 508376
10 | GRAPHIC | tm2522155d1_ex99-2img003.jpg | GRAPHIC | 213539
11 | GRAPHIC | tm2522155d1_ex99-2img004.jpg | GRAPHIC | 153961
12 | GRAPHIC | tm2522155d1_ex99-2img005.jpg | GRAPHIC | 197304
13 | GRAPHIC | tm2522155d1_ex99-2img006.jpg | GRAPHIC | 164472
14 | GRAPHIC | tm2522155d1_ex99-2img007.jpg | GRAPHIC | 192955
15 | GRAPHIC | tm2522155d1_ex99-2img008.jpg | GRAPHIC | 116931
16 | GRAPHIC | tm2522155d1_ex99-2img009.jpg | GRAPHIC | 180007
17 | GRAPHIC | tm2522155d1_ex99-2img010.jpg | GRAPHIC | 205924
18 | GRAPHIC | tm2522155d1_ex99-2img011.jpg | GRAPHIC | 256037
19 | GRAPHIC | tm2522155d1_ex99-2img012.jpg | GRAPHIC | 203313
20 | GRAPHIC | tm2522155d1_ex99-2img013.jpg | GRAPHIC | 174326
21 | GRAPHIC | tm2522155d1_ex99-2img014.jpg | GRAPHIC | 247623
22 | GRAPHIC | tm2522155d1_ex99-2img015.jpg | GRAPHIC | 239536
23 | GRAPHIC | tm2522155d1_ex99-2img016.jpg | GRAPHIC | 253476
24 | GRAPHIC | tm2522155d1_ex99-2img017.jpg | GRAPHIC | 172142
25 | GRAPHIC | tm2522155d1_ex99-2img018.jpg | GRAPHIC | 197814
26 | GRAPHIC | tm2522155d1_ex99-2img019.jpg | GRAPHIC | 142732
27 | GRAPHIC | tm2522155d1_ex99-2img020.jpg | GRAPHIC | 157771
28 | GRAPHIC | tm2522155d1_ex99-2img021.jpg | GRAPHIC | 174869
29 | GRAPHIC | tm2522155d1_ex99-2img022.jpg | GRAPHIC | 158021
30 | GRAPHIC | tm2522155d1_ex99-2img023.jpg | GRAPHIC | 128774
31 | GRAPHIC | tm2522155d1_ex99-2img024.jpg | GRAPHIC | 123511
32 | GRAPHIC | tm2522155d1_ex99-2img025.jpg | GRAPHIC | 54162
33 | GRAPHIC | tm2522155d1_ex99-2img026.jpg | GRAPHIC | 167803
| Complete submission text file | 0001104659-25-072447.txt |  | 7238872

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | fold-20250731.xsd | EX-101.SCH | 3044
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | fold-20250731_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | fold-20250731_pre.xml | EX-101.PRE | 22378
43 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2522155d1_8k_htm.xml | XML | 3552

Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 251169295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)